Previous close | 14.75 |
Open | 14.75 |
Bid | 13.65 |
Ask | 15.95 |
Strike | 1.00 |
Expiry date | 2026-01-16 |
Day's range | 14.75 - 14.75 |
Contract range | N/A |
Volume | |
Open interest | 6 |
Moderna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19 variant JN.1 to the FDA for the upcoming vaccination season.
Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Key Insights Institutions' substantial holdings in Novavax implies that they have significant influence over the...